Objective. Obesity, defined by anthropometric measures, is a well-known risk factor for knee osteoarthritis (OA), but there is a relative paucity of data regarding the association of body composition (fat and muscle mass) with risk of knee OA. We undertook this study to examine the longitudinal association of body composition categories based on fat and muscle mass with risk of incident knee OA.
INTRODUCTION
Obesity, a state of excess adiposity, is a major risk factor for knee osteoarthritis (OA) (1) . Prior studies of obesity and knee OA have mostly defined obesity using anthropometric measures, such as body weight or body mass index (BMI) (1) (2) (3) . However, anthropometric measurements are not exclusive measures of adiposity but instead reflect the composite of fat, muscle, and bone mass. Thus, it is not clear whether the effects of "BMI," typically interpreted as effects of obesity, are truly due to excess adiposity rather than to overall loading due to the combined weight of body mass. The few studies that have examined body composition in relation to knee OA have mostly been cross-sectional in design, which limits one's ability to make an inference regarding directionality of the association (4) (5) (6) . To better understand how total body mass as opposed to adiposity leads to knee OA, a longitudinal study of body composition and risk of knee OA is needed.
Further, studying body composition with knee OA lends an opportunity to examine another unique body composition state that cannot be well studied by anthropometric measures alone (i.e., sarcopenic obesity). While fat and muscle mass grow in synchrony in young healthy adults, uncoupling of the 2 processes can occur with aging, leading to a state of high fat mass with relatively low muscle mass, referred to as sarcopenic obesity (7) . A number of risk factors for development of sarcopenic obesity have been identified, such as low physical activity, inflammation, and malnutrition, among others (7). Thus, studying body composition allows evaluation of the additional risk posed by the state of high adiposity and low muscle mass over that of obesity without sarcopenia. Such insights would have novel clinical therapeutic implications in OA given the development and evaluation of treatments targeting sarcopenia. On the other hand, the absence of obesity may not necessarily be associated with reduced risk of developing knee OA, because those who are not obese can have either appropriate muscle mass or low muscle mass (i.e., sarcopenia). Sarcopenia itself is associated with several adverse outcomes, including functional limitations, but it is not known whether inappropriately low muscle mass as reflected by sarcopenia adversely impacts the risk of developing knee OA.
Thus, evaluating the effect of body composition on risk of knee OA may provide more insight into the relationship of obesity (versus that of body mass) to knee OA than traditional anthropometric measurements. Therefore, the aim of this study was to examine the longitudinal association of body composition defined by the relative presence of adiposity and sarcopenia with the risk of incident radiographic knee OA.
SUBJECTS AND METHODS
Study sample. We included participants from the Multicenter Osteoarthritis Study (MOST), a National Institutes of Health-funded longitudinal cohort of community-dwelling older adults with or at risk of knee OA, designed to study risk factors for knee OA. Details of the MOST study have been published elsewhere (8) . Subjects included in this study sample were those who were free of radiographic knee OA (defined below) at baseline and who completed follow-up at the 60-month clinic visit.
Exposure. Fat and muscle mass were estimated from whole-body dual x-ray absorptiometry (DXA) (Horizon DXA System, software version 12.0; Hologic) obtained at baseline using a published protocol (9) . Variables of fat and lean muscle mass (referred to hereafter as muscle mass) were recorded in kilograms from DXA. Sarcopenia was defined using the modified residual method used in geriatrics research as the lowest quintile of the residuals of appendicular skeletal muscle mass (sum of absolute muscle mass of upper and lower limbs), adjusting for age, height (in meters), and total body fat mass (in kilograms) (10) . To maintain consistency with the definition of sarcopenia, we divided total body fat mass (in kilograms) into quintiles, and the highest quintile was defined as obesity. Given the difference in body composition between men and women, obesity and sarcopenia were defined in a sex-specific manner. In a sensitivity analysis, obesity was defined by BMI ≥30 kg/m 2 instead of by DXA-derived fat mass. Subjects were then categorized into 4 sex-specific body composition categories: 1) obese nonsarcopenic, meeting the definition for obesity but not sarcopeniathese subjects will be referred to hereafter as obese; 2) sarcopenic obese, meeting the definitions for sarcopenia and obesity; 3) sarcopenic nonobese, meeting the definition for sarcopenia but not obesity-these subjects will be referred to hereafter as sarcopenic; and 4) nonsarcopenic nonobese, not meeting the definitions for obesity or sarcopenia (the referent category).
Outcome. Bilateral fixed-flexion posteroanterior knee radiographs were obtained at baseline and at the 60-month follow-up visit. Incident (new-onset) radiographic knee OA was defined as the presence of Kellgren/Lawrence (K/L) grade ≥2 in either or both knees at the 60-month follow-up visit, among those free of radiographic knee OA at baseline (i.e., K/L grade <2 in both knees at baseline) (11).
Confounders.
The following covariates were selected as confounders based on literature review: age, height, race, physical activity measured by the Physical Activity Scale for the Elderly (PASE) (12) , smoking status, Charlson comorbidity index (13) , and history of knee injury.
Statistical analysis.
We first assessed the longitudinal relationship of fat and muscle mass at baseline as continuous variables with the risk of incident radiographic knee OA over 60 months, using binomial regression with robust variance estimation to calculate risk ratios (RRs) with 95% confidence intervals (95% CIs). We then examined the longitudinal relationship of the body composition categories (obese, sarcopenic obese, sarcopenic, nonsarcopenic nonobese) defined at baseline with the risk of incident radiographic knee OA at the 60-month follow-up visit, using the same regression approach as described above. We adjusted for potential confounders as described above in the multivariable models.
In a sensitivity analysis, we defined obesity by BMI ≥30 kg/ m 2 instead of by DXA-derived fat mass, and we recategorized subjects based on this BMI-based definition to enable comparison of the results defined by body composition with the results defined by the standard anthropometric measure of obesity used in previous studies of knee OA. All analyses were performed in the overall study population and then stratified by sex due to our a priori hypothesis of effect measure modification by sex.
SAS software, version 9.3 (SAS Institute) was used to perform the analyses. The protocol was approved by the Institutional Review Board at Boston University School of Medicine and by the MOST study review and executive committee.
RESULTS
A total of 3,026 subjects were enrolled in the MOST study, of whom 1,696 were included in the body composition categories (mean age 62 years, 61% women, and mean BMI 30 kg/m 2 ). Our final analytic cohort was 1,653 subjects who were free of radiographic OA at baseline, after excluding those subjects not completing the 60-month visit. Among those included, 315 subjects developed incident radiographic knee OA by the 60-month follow-up visit (19%). The baseline characteristics of subjects by body composition categories (obese, sarcopenic obese, sarcopenic, nonsarcopenic nonobese) are outlined in Table 1 . The differences in body weight, total body fat, and appendicular skeletal muscle mass among the groups were in the expected direction.
In the multivariable adjusted analysis of fat and muscle mass assessed as linear variables, we found greater fat mass to be numerically and statistically associated with increased risk of knee OA at 60 months in the overall population (RR (Table 3) . When stratified by sex, the risk of knee OA in women was 87% greater in obese subjects (RR 1.87 [95% CI 1.37-2.54]) and 60% greater in sarcopenic obese subjects (RR 1.60 [95% CI 0.93-2.77]) compared with nonsarcopenic nonobese subjects, although the latter comparison was not statistically significant (Table 3 ). In men, the risk of knee OA was almost 2-fold greater in obese subjects (RR 1.92 [95% CI 1.24-3.00]) Table 3 . * RR = risk ratio; 95% CI = 95% confidence interval. † Adjusted for age, height, race, Physical Activity Scale for the Elderly score, smoking, Charlson comorbidity index, and knee injury.
DISCUSSION
In this large longitudinal study of the risk of knee OA in relation to DXA-derived body composition categories (obesity, sarcopenic obesity, and sarcopenia), we found increased risk of radiographic knee OA among obese women and men. Increased risk of knee OA was also found in sarcopenic obese women and men, although the results did not reach statistical significance in men. While the relationship of anthropometrically measured obesity with risk of knee OA is well known, this is the first longitudinal study to demonstrate an increased risk of knee OA with body composition-based obesity and also sarcopenic obesity. Our findings have implications for management of knee OA, such that weight loss interventions should target both high fat mass and low muscle mass. Similar results of increased risk with obesity and sarcopenic obesity were noted when obesity was defined by BMI instead of by DXA-derived fat mass and muscle mass.
The few previous studies that have examined the association of body composition with knee OA have found conflicting results (4) (5) (6) 14) . Issues with study design and lack of consistency in definition of obesity and sarcopenia from body composition assessment (i.e., fat and muscle mass) partly explain discordant results. For example, consistent with our results, a cross-sectional study by Lee et al found increased prevalence of radiographic knee OA among obese and sarcopenic obese subjects compared with nonsarcopenic nonobese individuals (4). Of note, sarcopenia was defined by low muscle mass, while obesity was defined by BMI, similar to our sensitivity analysis. In contrast, another cross-sectional study found anthropometric measures (BMI and body weight) more strongly associated with radiographic knee OA than fat or lean muscle mass from DXA assessed separately (5).
Yet another cross-sectional study found increasing odds of knee OA with increasing quartiles of BMI and fat mass, but no association was found with lower extremity muscle mass (6) . In the same study, obese subjects with a low percentage of lower extremity muscle mass (comparable to sarcopenic obese subjects in our study) and nonobese subjects with a low percentage of lower extremity muscle mass (comparable to sarcopenic subjects in our study) were found to have greater odds of radiographic OA compared with nonobese subjects with normal lower extremity muscle mass. In contrast, obese subjects with normal lower extremity muscle mass (akin to obese subjects in our study) had no additional increased risk of knee OA (6) . Further, yet another study using bioimpedance for assessment of body composition found increasing risk of severe radiographic OA and joint space narrowing with increase in fat and muscle mass (in separate analyses), although more variability was explained by muscle mass (14) . To overcome some of the limitations of previous studies, we designed a longitudinal study using incident radiographic knee OA as the outcome and defined both obesity and sarcopenia based on fat and muscle mass assessment from whole-body DXA, using definitions described in previous studies of body composition (7, 10) .
Knee OA is known to affect women disproportionately, but the reason for this gender disparity is not known. Despite the known difference in body composition between men and women, a similar increased risk of knee OA with adiposity for obese and sarcopenic obese categories was noted for both sexes, although this was not statistically significant in men. Of note, in additional analyses (see Supplementary Table 1 , available on the Arthritis & Rheumatology web site at http://onlinelibrary.wiley.com/doi/10.1002/art.40692/ abstract), upon additionally adjusting for body weight in the multivariable analysis of DXA-derived body composition categories and risk of knee OA, the association of obesity in women attenuated slightly, but in men the effect estimates attenuated considerably. These results might suggest a differential effect of loading on risk of knee OA by sex, although body weight may be problematic to use as a surrogate marker for loading effect. Sarcopenia was not significantly associated with risk of knee OA in men or women, although the effect estimates in men showed a trend toward a protective effect. Our results suggest that the risk of knee OA in both women and men is primarily conferred by adiposity, with perhaps a lesser independent effect of muscle mass.
Adiposity confers increased risk of many diseases primarily through a metabolic effect of adipose tissue products (adipokines). The role of adipokines has been demonstrated in knee OA (15) . However, there is also evidence to suggest that increased loading across the joint in obesity leads to cartilage damage and knee OA (16) . While the present study did not provide direct evidence for a metabolic or mechanical pathway for knee OA in obesity, it indicates the important role of adiposity (i.e., fat mass over muscle mass).
Although ours is the first longitudinal study that we are aware of to address this question, we acknowledge that it has limitations. First, the sample size of the sarcopenic obesity category was small, limiting our ability to precisely estimate the relationship of sarcopenic obesity with risk of knee OA in men, although all of the effect estimates were consistent in the direction and magnitude of effect. Second, the subjects in this study were primarily Caucasians; thus, these findings may not be generalizable to other racial groups, although we do not know of a biologic hypothesis to suggest that obesity and sarcopenia have effects that differ by race. Third, as physical activity levels can affect body composition, the use of the PASE instrument as a measure of physical activity level to control for its potential confounding effects is a limitation. Fourth, a quintile-based approach used to define obesity and sarcopenia may not be generalizable to other populations. However, these are approaches that have been developed to study body composition, particularly the combination of sarcopenia with obesity. Fifth, as with any observational study, there is a possibility of residual confounding.
Our study also has several strengths. The longitudinal design allows us to infer directionality. We assessed the relative | 237 individual and combined effects of fat and muscle mass by combining the categories of obesity and sarcopenia. The comprehensive data with validated measurement of knee OA and whole-body DXA in large numbers of subjects constitute an additional strength of our study.
In conclusion, body composition assessment allows for new insights into the association of obesity with knee OA, especially the finding of increased risk conferred by sarcopenic obesity. Preventive efforts may need to focus not only on reducing obesity but also on ameliorating sarcopenic obesity to reduce the burgeoning incidence and prevalence of knee OA.
